Conference 2017

Building Success Together from Knowledge to Innovation

What does “success” in Early Psychosis Intervention (EPI) services mean to you?

Join EPION for a two-day conference and explore different ways to define and understand success. During this conference you will:

  • Connect with your colleagues to share and learn about innovations in EPI practice that help bring us closer to our visions of success as clinicians, program managers, persons with lived experience of psychosis and family members.
  • Find out about the learnings and successes from programs that have implemented new practices, including those inspired by EPION’s recent think tanks on education and outreach, family work, metabolic monitoring, psychological therapies, knowledge exchange, evaluation and monitoring, and psychosis and cannabis.
  • Understand the latest data and evidence on EPI and what it means for clinical practice and how we understand success in this field.

Plenary Speakers

  • George Foussias, MD PhD FRCPC
    Psychiatrist and Scientist
    Slaight Family Centre for Youth in Transition, Campbell Family Mental Health Research Institute, and Schizophrenia Division Centre for Addiction and Mental Health
  • Nev Jones, PhD
    Community Psychologist and Director
    Felton Institute’s CCOR (Client Centered Outcomes Research in Public Mental Health)
  • Philip Tibbo, MD FRCPC
    Director / Co-Director
    Nova Scotia Early Psychosis Program / Nova Scotia Psychosis Research Unit
Dr. George Foussias is an Assistant Professor in the Department of Psychiatry and Institute of Medical Science, Faculty of Medicine, University of Toronto. He is a Clinician-Scientist located at the Campbell Family Mental Health Research Institute and Schizophrenia Division at the Centre for Addiction and Mental Health (CAMH), where he leads the Virtual Reality and Behavioural Neuroscience Research Laboratory.

Research Interests

Dr. Foussias’ research focuses on advancing our understanding and treatment of motivational deficits, and related negative symptoms, seen in severe mental illnesses. His approaches include longitudinal phenomenology and outcome studies, psychopharmacology treatment trials, neuroimaging, and the development of novel assessment methodologies using virtual reality, motion-tracking technology, and computerized assessments to tap into real-world performance and functioning. The ultimate goal of this work is to guide the development of more effective treatments for motivational deficits, which stand as an important barrier to functional recovery in severe mental illnesses.
About speaker 2
About speaker 3

Click to Register